Basic Information
NOVORAPID FLEXPEN INJECTION 100 u/ml
INJECTION
Regulatory Information
SIN12189P
February 6, 2003
Prescription Only
Therapeutic
INTRAVENOUS, SUBCUTANEOUS
August 10, 2023
May 30, 2025
XA10AB05
Company Information
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
NOVO NORDISK PHARMA (SINGAPORE) PTE LTD
Active Ingredients
Insulin Aspart
Strength: 100 u/ml
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to the active substance or any of the excipients.
Indication Information
**Therapeutic indications** Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.